Despite the accumulating evidence of feasibility, safety, and positive functional outcomes of the Expanded Transcanal Transpromontorial Approach, its spread has been restricted to few centers across the world.
Measuring Vestibular Schwannoma Signal Intensity on Enhanced MRI May Help Predict Growth
Growing vestibular schwannomas (VSs) show higher signal intensities on Gd-enhanced MRIs and, therefore, measuring signal intensity of VS on Gd-enhanced MRI may aid in predicting VS growth.
Does Stereotactic Radiosurgery Worsen Vestibular Symptoms in Patients with Vestibular Schwannoma?
Sterotactic radiosurgery (SRS) for the treatment of VS can be associated with increased balance symptoms, often within the first six months after treatment.
Aspirin Shows No Association with Vestibular Schwannoma Growth
Findings did not demonstrate an association between tumor size and aspirin intake.
MRI Surveillance Should Extend to 10 Years Post- Op for Vestibular Schwannoma Patients
The current recommended MRI surveillance schedule includes MRIs at one, five, and 10 years postoperatively
What Is the Risk of Malignant Transformation of Vestibular Schwannoma Following Radiosurgery?
Radiosurgical treatment of vestibular schwannomas is safe and effective.
What Is the Risk of Malignant Transformation of Vestibular Schwannoma Following Radiosurgery?
Radiosurgical treatment of vestibular schwannomas is safe and effective
Vestibular Schwannoma Quality-of-Life Assessment Shows Minimal Clinically Signicant Difference
The MCID can be a useful tool to evaluate and compare group outcomes
Vestibular Schwannoma Quality-of-Life Assessment Shows Minimal Clinically Significant Difference
MRI scans, microsurgery, and radiosurgery treatment modalities measured for quality-of-life impact
Combined Otolaryngology Spring Meetings a Forum for Otolaryngologists to Listen, Debate, Network
Sessions cover latest medical research, technology, issues in otolaryngology